Shoulder Innovations (NYSE:SI) Shares Up 11% – Should You Buy?

by · The Markets Daily

Shoulder Innovations, Inc. (NYSE:SIGet Free Report) shares were up 11% during trading on Monday . The stock traded as high as $22.53 and last traded at $22.3830. 173,098 shares traded hands during mid-day trading, an increase of 16% from the average daily volume of 149,042 shares. The stock had previously closed at $20.16.

Analysts Set New Price Targets

SI has been the topic of several research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Shoulder Innovations in a research report on Monday, June 29th. Piper Sandler reissued an “overweight” rating and issued a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th. Five analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $21.00.

Read Our Latest Stock Analysis on SI

Shoulder Innovations Trading Up 11.0%

The stock’s fifty day moving average price is $17.05 and its 200 day moving average price is $15.10. The stock has a market cap of $464.22 million and a P/E ratio of -0.13. The company has a current ratio of 11.81, a quick ratio of 10.04 and a debt-to-equity ratio of 0.11.

Shoulder Innovations (NYSE:SIGet Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The company had revenue of $16.71 million during the quarter. Equities research analysts expect that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current year.

Insider Activity

In other news, COO Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $18.68, for a total transaction of $296,190.08. Following the completion of the transaction, the chief operating officer directly owned 273,320 shares in the company, valued at approximately $5,105,617.60. This trade represents a 5.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 29.00% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SI. Rhumbline Advisers purchased a new position in Shoulder Innovations during the third quarter valued at $54,000. Vanguard Group Inc. purchased a new stake in shares of Shoulder Innovations in the third quarter worth $1,836,000. Deerfield Management Company L.P. purchased a new stake in shares of Shoulder Innovations in the third quarter worth $6,056,000. Bank of America Corp DE bought a new position in shares of Shoulder Innovations during the third quarter valued at $322,000. Finally, Citadel Advisors LLC purchased a new position in shares of Shoulder Innovations in the 3rd quarter worth about $628,000.

About Shoulder Innovations

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

See Also